Neutra Corp. Acquires VIVIS Corp.

Vireo Growth Inc to Acquire Certain Assets of The Cannabist Company Holdings Inc

July 20, 2026

Healthcare Services

Vireo Growth Inc, through its subsidiary Vireo Health of Arcadia, LLC, entered into a definitive purchase agreement to acquire certain cannabis cultivation, manufacturing, and retail operations from subsidiaries of The Cannabist Company Holdings Inc across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia. The deal consideration is up to US$35 million (subject to regulatory approvals), with closing expected in stages through 2026 and 2027. Vireo expects the transaction to add up to 25 dispensaries and strengthen its vertically integrated presence in multiple limited-license cannabis markets.

Vireo Growth Inc. Acquires C21 Investments Inc.

June 15, 2026

Healthcare Services

Vireo Growth Inc. entered into a definitive arrangement agreement to acquire all outstanding common shares of C21 Investments Inc. for stock consideration. The deal is expected to expand Vireo’s Nevada footprint by adding three dispensaries and approximately 104,000 sq. ft. of cultivation and production capacity.

Vivo Infusion Acquires Neurology Institute of San Antonio and Vista Infusions

January 9, 2025

Healthcare Services

Vivo Infusion has acquired the Neurology Institute of San Antonio (NISA) and Vista Infusions, expanding its ambulatory infusion and neurology services footprint in Texas. The deal brings Vivo to nearly 90 infusion centers across 15 states and increases its presence in Texas to about 20 locations; financial terms were not disclosed.

MediPharm Labs Corp. Acquires VIVO Cannabis Inc.

April 1, 2023

Pharmaceuticals

Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.

BevCanna Enterprises Acquires Naturally Pure Therapy Products Corp.

September 4, 2020

Consumer Products

BevCanna Enterprises Inc. entered into a share exchange agreement to acquire Naturally Pure Therapy Products Corp., a direct-to-consumer e-commerce retailer of natural health, nutraceutical and hemp-based CBD products. BevCanna will issue 30,000,000 common shares (deemed $0.20 per share; total deemed consideration C$6,000,000) in exchange for all issued and outstanding securities of Pure Therapy, providing BevCanna with an established e-commerce platform, ~22,000 customers and recurring subscription revenue to support launch and expansion of hemp-based CBD beverages into North America and Western Europe.

Aurora Cannabis Acquires Reliva LLC

May 28, 2020

Consumer Products

Aurora Cannabis Inc. completed the acquisition of Reliva, LLC, a leading U.S. hemp-derived CBD consumer brand, in a transaction valued at approximately US$40 million in Aurora common shares plus an earn-out of up to US$45 million. The deal gives Aurora immediate U.S. retail CBD scale and distribution (Reliva products are sold in over 20,000 stores) and aims to combine Aurora's product innovation and international footprint with Reliva's U.S. retail relationships to accelerate growth.